Jain et al. demonstrated that TRPC6 was upregulated in PAMSCs isolated from PAH patients, and inhibition of TRPC6 by BI-749327 could inactivate PI3K/AKT/mTOR pathways to restore pulmonary vascular remodeling [17]. Here, TRPC6 is linked to pulmonary arterial hypertension.